HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): a new angiotensin-converting enzyme inhibitor.

Abstract
The study reported here prospectively evaluated the prevention of diuretic-induced secondary hyperaldosteronism and hypokalemia by a converting enzyme inhibitor, enalapril (MK 421). Eighteen normal subjects were randomized into three groups: (1) a HCTZ group (hydrochlorothiazide (HCTZ) 50 mg/day); (2) a MK-421 group (MK-421 10 mg/day); and (3) a HCTZ + MK-421 group [HCTZ 50 mg/day plus MK-421 10 mg/day]. Following a five-day control and a 28-day treatment period, the HCTZ group demonstrated an attenuated but persistent secondary hyperaldosteronism and hypokalemia, the MK-421 group manifested a gradual decline in aldosterone secretion, and the HCTZ + MK-421 group had a delayed but effective correction of secondary hyperaldosteronism and hypokalemia at 28 days but not before. In conclusion, MK-421 reversed diuretic-induced secondary hyperaldosteronism and hypokalemia after 28 days of hydrochlorothiazide therapy. Therefore, converting enzyme inhibitors, such as enalapril, provide useful adjunctive therapy in diuretic-treated patients, but potassium supplementation may be required before the start of four weeks of combined therapy.
AuthorsG T Griffing, B H Sindler, S A Aurecchia, J C Melby
JournalMetabolism: clinical and experimental (Metabolism) Vol. 32 Issue 7 Pg. 711-6 (Jul 1983) ISSN: 0026-0495 [Print] United States
PMID6306388 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Dipeptides
  • Diuretics
  • Electrolytes
  • Hydrochlorothiazide
  • Enalapril
  • Renin
Topics
  • Angiotensin-Converting Enzyme Inhibitors
  • Dipeptides (therapeutic use)
  • Diuretics (adverse effects, antagonists & inhibitors)
  • Electrolytes (metabolism)
  • Enalapril
  • Humans
  • Hydrochlorothiazide (antagonists & inhibitors)
  • Hyperaldosteronism (chemically induced, prevention & control)
  • Hypokalemia (chemically induced, prevention & control)
  • Random Allocation
  • Renin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: